Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.
about
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dose-reduced fludarabine, cycl ...... reserved therapeutic efficacy.
@en
type
label
Dose-reduced fludarabine, cycl ...... reserved therapeutic efficacy.
@en
prefLabel
Dose-reduced fludarabine, cycl ...... reserved therapeutic efficacy.
@en
P2093
P2860
P1433
P1476
Dose-reduced fludarabine, cycl ...... preserved therapeutic efficacy
@en
P2093
Ali Bazargan
David Westerman
Dennis A Carney
E Henry Januszewicz
H Miles Prince
John F Seymour
Robin Filshie
Thomas E Lew
P2860
P304
P356
10.3109/10428194.2015.1096353
P577
2015-11-20T00:00:00Z